medigraphic.com
SPANISH

Revista Colombiana de Bioética

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 1

Next >>

Revista Colombiana de Bioética 2020; 15 (1)

Heritable Genome Editing: An Exploratory Study from the Bioethical Principle of Beneficence

Caro-Romero HD
Full text How to cite this article

Language: Spanish
References: 35
Page:
PDF size: 201.26 Kb.


Key words:

CRISPR-Cas9, preventive genomics, gene therapy, genome improvement, bioethical principle of beneficence.

ABSTRACT

Purpose/Context. This article seeks to understand the meaning that the possibility of making genetic changes in human beings before birth would have for a group of individuals residing in Bogotá. The study focuses on the application of the CRISPR-Cas9 genome editing technique from the perspective of the bioethical principle of beneficence, i.e., to do the greatest good possible.
Method/Approach. First, the CRISPR-Cas9 technique and the bioethical principle of beneficence are theoretically reviewed. Then, international regulatory documents on genome editing are examined. Based on this, a video-based survey is administered to find out the hypothetical decision that a group of lay professionals would make on bioethical issues compared to a group of university students who have received bioethical training.
Results/Findings. Genome editing intended for prevention or therapy was approved by both groups, although with differences. Genome improvement was generally rejected for being immoral. However, both groups were open to accepting it but only as genome preparation for future generations due to the effects of climate change.
Discussion/Conclusions/Contributions. The bioethical principle of beneficence is insightful as it suggests both the private and common good. Moral reservations over heritable genome editing are also corroborated.


REFERENCES

  1. Abarca Barriga, Hugo H., Miguel Chávez Pastor, Milana Trubnykova, Jorge E. LaSerna-Infantes, y Julio A. Poterico. 2018. “Factores de riesgo en las enfermedadesgenéticas.” Acta Médica Peruana 35, no. 1: 43-50.

  2. Beauchamp, Tom L., y James F. Childress. 2013. Principles of Biomedical Ethics. NewYork: Oxford University Press.

  3. Bernardo-Álvarez, Mª Ángela. 2017. “La revolución de CRISPR-Cas9: una aproximacióna la edición genómica desde la bioética y los derechos humanos.” RevistaIberoamericana de Bioética 3: 1-13. https://doi.org/10.14422/rib.i03.y2017.003

  4. Bick, David, Marilyn Jones, Stacie L Taylor, Ryan J Taft, y John Belmont. 2019.“Case for genome sequencing in infants and children with rare, undiagnosed orgenetic diseases.” Journal of Medical Genetics 56, no. 12: 783-791. http://dx.doi.org/10.1136/jmedgenet-2019-106111

  5. Boddington, Paula. 2012. Ethical challenges in genomics research. Springer.

  6. Boggio, Andrea, Cesare P. R. Romano, y Jessica Almqvist. 2020. Human GermlineGenome Modification and the Right to Science. Cambridge University Press. https://doi.org/10.1017/9781108759083

  7. Cabero Almenara, Julio, Dominga Márquez Fernández, Soledad Josefa DomeneMartos, Julio Manuel Barroso Osuna, Ana María Duarte Hueros, Antonio FeriaMoreno, y Juan Antonio Morales Lozano. 1997. “La introducción del vídeocomo instrumento de conocimiento en la enseñanza universitaria.” Video.https://idus.us.es/handle/11441/24691

  8. Caro-Romero, Henry David. 2018. “Mejoramiento Deportivo Postconvencional,Cine y Bioética.” The Journal of the Latín American Socio-Cultural Studies of Sport 8,no. 2: 103-119. http://dx.doi.org/10.5380/jlasss.v8i2.58983

  9. Caro-Romero, Henry David. 2016. “Posthumanismo, Cine y Educación.” PhilosophicalViews 4. http://filozofski-pogledi.weebly.com/pogled-u-politiku

  10. Casado, María, Maria do Céu Patrão Neves, Itziar de Lecuona, Ana Sofia Carvalho,y Joana Araújo. 2016. Declaración sobre integridad científica en investigación einnovación responsable: http://www.publicacions.ub.edu/refs/observatoriBioEticaDret/documents/08489.pdf

  11. Comité de Bioética de España. 2019. Declaración del Comité de Bioética de Españasobre la edición genómica en humanos. http://www.bioeticayderecho.ub.edu/es/declaracion-del-comite-de-bioetica-de-espana-sobre-la-edicion-genomica-en-humanos

  12. Consejo Nuffield de Bioética. 2018. Genome editing and human reproduction: socialand ethical issues. http://nuffieldbioethics.org/

  13. Consejo Nuffield de Bioética. 2016. Encuesta: Edición genómica en reproducción humana.http://nuffieldbioethics.org/wp-content/uploads/Genome-editing-survey-preview.pdf

  14. Costa, Flavia, y Pablo Rodríguez. 2017. La salud inalcanzable. Biopolítica molecular ymedicalización de la vida cotidiana. Editorial Eudeba.

  15. Department of Health, Education, and Welfare. 1979. The Belmont Report. https://www.hhs.gov/ohrp/regulations-and-policy/belmont-report/read-the-belmont-report/index.html

  16. Doudna, Jennifer. 2016. “How CRISPR lets us edit our DNA.” TED video, September,2015, 15:45. https://www.ted.com/talks/jennifer_doudna_how_crispr_lets_us_edit_our_dna

  17. Genome editing. 2016. Nuffield Council on Bioethics. http://nuffieldbioethics.org/wp-content/uploads/Genome-editing-an-ethical-review.pdf

  18. González-Lamuño, Domingo, y Miguel García Fuentes. 2008. “Enfermedades debase genética.” Anales del Sistema Sanitario de Navarra 31, no. 2: 105-126. http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1137-66272008000400008

  19. Hendriks, Saskia, Noor A. A. Giesbertz, Annelien L. Bredenoord, y Sjoerd Repping.2018. “Reasons for being in favour of or against genome modification: Asurvey of the Dutch general public.” Human Reproduction Open, no. 3: hoy008.https://doi.org/10.1093/hropen/hoy008

  20. Ishii, Tetsuya. 2015. “Germline genome-editing research and its socioethical implications.”Trends in Molecular Medicine 21, no. 8:473481. https://doi.org/10.1016/j.molmed.2015.05.006

  21. Kingsmore, Stephen. 2012. “Comprehensive carrier screening and moleculardiagnostic testing for recessive childhood diseases.” PLOS Currents 4 (May 2):e4f9877ab8ffa9. https://dx.doi.org/10.1371%2F4f9877ab8ffa9

  22. Lander, Eric S., Françoise Baylis, Feng Zhang, Emmanuelle Charpentier, Paul Berg,Catherine Bourgain, Bärbel Friedrich, et al. 2019. “Adopt a moratorium on heritablegenome editing.” Nature 567 (March): 165-168. https://doi.org/10.1038/d41586-019-00726-5

  23. López Frías, Francisco Javier. 2013. “La mejora genética ¿el dopaje del siglo XXI?”En Bioética, neuroética, libertad y justicia, 1275-1289. Universidad de Valencia.https://dialnet.unirioja.es/servlet/articulo?codigo=4388261

  24. Missá, Jean Noël. 2019. “Conferencia inaugural. XXV Seminario Internacional deBioética: Dimensiones Globales de la Bioética.” YouTube video, 10 de junio,2020, 58:35. https://www.youtube.com/watch?v=GLMkIWmAAR4

  25. Ormond, Kelly, Douglas P. Mortlock, Derek T. Scholes, Yvonne Bombard, LawrenceC. Brody, W. Andrew Faucett, Nanibaa’ A. Garrison, et. al. 2017. “HumanGermline Genome Editing.” American Journal of Human Genetics 101, no. 2:167–176. https://doi.org/10.1016/j.ajhg.2017.06.012

  26. Pareja Arcila, Marta Luz. 2017. Situación actual de las enfermedades huérfanasen Colombia. CES Derecho 8, no. 2: 231-241. http://dx.doi.org/10.21615/cesder.8.2.2

  27. Romeo Casabona, Carlos María. 2011. Los nuevos horizontes de la investigación genética.Granada: Comares Editorial.

  28. Santaló-Pedro, Josep. 2017. “Edición genómica. La hora de la reflexión.” Revistade Bioética y Derecho, no. 40: 157-165. http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1886-58872017000200012

  29. Seitz, Joshua D. 2018. “Striking a Balance: Policy Considerations for Human GermlineModification.” Santa Clara Journal of International Law 16, no. 1: 60-100.https://digitalcommons.law.scu.edu/scujil/vol16/iss1/3

  30. Simón Lorda, Pablo, Azucena Couceiro Vidal, y Inés María Barrio Cantalejo.1999.“Una metodología de análisis de los problemas bioéticos.” En Bioética para casosclínicos, 233-238. Editorial Triacastela. https://dialnet.unirioja.es/servlet/articulo?codigo=2332422

  31. Torres Yabar, Alessandra Sofia, Lauren Elin Guertin, y Robert M. McGuire. 2018.Public Perception of Human Applications of CRISPR Gene Editing. https://digitalcommons.wpi.edu/iqp-all/2911

  32. Tovar Mosquera, Juan Vianey. 2016. "Eugenesia en Colombia. Un problema dejusticia social." Revista Colombiana De Bioética 11, no. 1: 35-53. https://doi.org/10.18270/rcb.v11i1.1623

  33. Vilas Boas Reis, Émilien y Bruno Torquato de Oliveira. 2019. “CRISPR-CAS9, Bioseguridady bioética: un análisis jusfilosófico-ambiental de la ingeniería.” Veredasdo Direito, Belo Horizonte 16, no. 34: 123-152. http://revista.domhelder.edu.br/index.php/veredas/article/viewFile/1490/24743

  34. Wildhaber, Thomas, Séverine Rion Logean, y Christoph Nabholz. 2017. “CRISPR-Hacking the biological hard drive.” Risk Dialogue Series: Genomic medicine.Zurich: Swiss Re.

  35. Unesco. 2005. Declaración Universal sobre Bioética y Derechos Humanos. http://portal.unesco.org/es/ev.php-URL_ID=31058&URL_DO=DO_TOPIC&URL_SECTION=201.html




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Revista Colombiana de Bioética. 2020;15